Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence Synopsys Releases Financial Results for Second Quarter of Fiscal Year 2026 DeepSeek The Chinese AI Model Impressing Silicon Valley Despite Chip Constraints Nvidia Stock Dips PostEarnings Why Market Skeptics May Be Overlooking Key Fundamentals Record Short Bets Converge with Iran Deal Hopes as Markets Near AllTime Highs Citius Pharmaceuticals CTXR Draws Analyst Attention Among Penny Stock Candidates Nabors Industries Q1 2026 Earnings Loss Narrows as EPS Beats Estimates but Shares Slip LEN Q1 2026 Earnings EPS Falls Short of Estimates Amid Modest Stock Gain InterDigital IDCC Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Caution NEWTI Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed CGEM Q1 2026 Earnings NarrowerthanExpected Loss and Strategic Pipeline Progress Chemours CC Gains 34 as Stock Approaches Key Resistance Level Aspire Biopharma ASBP Declines Over 6 as Shares Approach Critical Support GBank Financial Holdings Inc GBFH Holds Near Support Amid Quiet Session Biomea Fusion BMEA Stages a Rebound Testing Key Resistance After a 365 Gain Microsoft in Talks to Supply Custom AI Chips to Anthropic Following 5 Billion Investment Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues